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Summary
Satellite cells are the resident stem cells of skeletal muscle. Mitotically quiescent in mature muscle, they can be activated to proliferate
and generate myoblasts to supply further myonuclei to hypertrophying or regenerating muscle fibres, or self-renew to maintain the
resident stem cell pool. Here, we identify the transcriptional co-factor Yap as a novel regulator of satellite cell fate decisions. Yap
expression increases during satellite cell activation and Yap remains highly expressed until after the differentiation versus self-renewal
decision is made. Constitutive expression of Yap maintains Pax7+ and MyoD+ satellite cells and satellite cell-derived myoblasts,
promotes proliferation but prevents differentiation. In contrast, Yap knockdown reduces the proliferation of satellite cell-derived
myoblasts by <40%. Consistent with the cellular phenotype, microarrays show that Yap increases expression of genes associated with
Yap inhibition, the cell cycle, ribosome biogenesis and that it represses several genes associated with angiotensin signalling. We also
identify known regulators of satellite cell function such as BMP4, CD34 and Myf6 (Mrf4) as genes whose expression is dependent on
Yap activity. Finally, we confirm in myoblasts that Yap binds to Tead transcription factors and co-activates MCAT elements which are
enriched in the proximal promoters of Yap-responsive genes.
Key words: Satellite cells, Skeletal muscle, Yes-associated protein (Yap), Hippo pathway
Introduction
Yes-associated protein (Yap) is a transcriptional co-factor within
the Hippo signal transduction pathway. Yap is phosphorylated at
Ser127 and other residues by its upstream kinase Lats1/2 which
in turn is phosphorylated and regulated by Mst1/2 and auxiliary
proteins (Pan, 2010; Sudol and Harvey, 2010; Zhao et al., 2011).
Yap can also be regulated independently of the Hippo pathway
by a-catenin (Schlegelmilch et al., 2011), b-catenin (Heallen
et al., 2011) or angiomotin (Chan et al., 2011; Oka et al., 2012).
Yap, its paralogue Taz (transcriptional coactivator with PDZ-
binding motif) and Vgll1-4 (vestigial-like, Vito, Tondu) all bind
and co-activate Tead1-4 (TEA/ATTS domain/TEF/scalloped)
transcription factors by forming protein complexes via specific
Tead-co-factor binding domains (Halder et al., 1998; Mahoney
et al., 2005; Mielcarek et al., 2002; Pobbati et al., 2012; Vassilev
et al., 2001; Maeda et al., 2002). Co-activated Teads then
regulate gene expression by binding via their <70 amino acid
TEA/ATTS DNA-binding domain to so-called MCAT elements
(muscle C, A and T; 59-CATTCC-39). MCAT elements are
located in the promoter or enhancer regions of key genes that
either regulate early myogenesis (e.g. MyoD, Myf5, Mrf4),
proliferation (e.g. cyclin D1), terminal differentiation (myogenin)
or are expressed in terminally differentiated skeletal, cardiac or
smooth muscle (Benhaddou et al., 2012; Mizuno et al., 2012;
Ribas et al., 2011; Yoshida, 2008). Whilst Yap is capable of co-
activating a host of other transcription factors (Saucedo and
Edgar, 2007), Yap and Tead mostly occupy the same promoters.
A chip-on-chip analysis in MCF10A mammary epithelial cells
revealed that Yap and Tead1 occupy the same promoters in
,80% of the cases (Zhao et al., 2008) suggesting that Yap co-
activation of Tead isoforms is the main mechanism by which Yap
regulates gene expression.
The elements and function of the Hippo pathway were first
identified during genetic screens for tumour suppressors in
Drosophila melanogaster, where knockout of the inhibitory
components upstream of the Yap homologue Yorkie resulted in
overgrowth phenotypes (Harvey and Tapon, 2007). In 2007 two
publications implicated the Hippo pathway in mammalian organ
size control by overexpressing constitutively active hYAP1
S127A in the liver which triggered a <4-fold liver hypertrophy
(Camargo et al., 2007; Dong et al., 2007). In addition to organ
growth, Yap also regulates the identity and cell fate of several
types of adult stem and/or progenitor cells. These include
intestinal progenitors (Camargo et al., 2007), hepatic oval cells
(Lee et al., 2010), neural stem cells (Cao et al., 2008) and
epidermal stem cells (Schlegelmilch et al., 2011). In these stem
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and progenitor cells Yap is generally required for their identity or
‘stemness’ (Camargo et al., 2007; Ramalho-Santos et al., 2002),
promoting proliferation but inhibiting differentiation.
We have recently demonstrated that Yap and other members of
the Hippo pathway are expressed in skeletal muscle and that Yap
promotes proliferation but inhibits differentiation of C2C12
myoblasts (Watt et al., 2010). C2C12 myoblasts are an
immortalised cell line, can fuse to form myotubes and are likely
derived from muscle satellite cells, which are the resident stem
cells of adult skeletal muscle (Mauro, 1961; Collins et al., 2005).
The regulation of satellite cell fate can be studied in satellite cells
cultured in their niche ex vivo (Collins and Zammit, 2009; Zammit
et al., 2004). Quiescent satellite cells express the paired-box
transcription factor Pax7 (Pax7+/MyoD2). When satellite cells
become activated and re-enter the cell cycle, MyoD is expressed
(Pax7+/MyoD+) in culture ex vivo or in response to injury and
hypertrophic stimuli in vivo (Scharner and Zammit, 2011; Relaix
and Zammit, 2012). MyoD binds to thousands of genes and
induces chromatin modifications which presumably open up the
chromatin for sequence-specific transcription factors (Cao et al.,
2010). Activated satellite cells then proliferate and either
differentiate (Pax72/myogenin+) or self-renew and return to
quiescence (Pax7+/MyoD2). Satellite cells are required for
postnatal growth and muscle repair after injury (Lepper et al.,
2011) but muscle hypertrophy can occur short term in muscle that
is to more than 90% depleted of Pax7+ satellite cells (McCarthy
et al., 2011). The proliferative and regenerative capacity of satellite
cells is enormous: it has been estimated that one transplanted
satellite cell (termed muscle stem cell in that paper due to the
FACS-isolation method used) can differentiate and give rise to an
estimated 20,000–80,000 progeny during repeated injury-
regeneration cycles (Sacco et al., 2008). Also a purified,
transplanted population of FACS-isolated skeletal muscle
precursors (termed SMPs, which are likely largely composed of
satellite cells) contributed with high efficiency to muscle fibres of
dystrophin-deficient mdx mice (Cerletti et al., 2008).
Previous studies have shown that the activation, proliferation,
differentiation and self-renewal of satellite cells is regulated by
several signal transduction pathways including the Notch, Wnt
and BMP pathways (Ono et al., 2011; Otto et al., 2008; Mourikis
et al., 2012). Here, we demonstrate for the first time that the
Hippo pathway member Yap plays a key role in satellite cell
proliferation and fate. We show that Yap expression increases
greatly during satellite cell activation and Yap remains elevated
until after activated satellite cells either differentiate or self-
renew. We report that constitutive Yap activity expands the pool
of activated, Pax7 and MyoD-positive satellite cells and satellite
cell-derived myoblasts but prevents their differentiation.
Consistent with these observations, microarrays identify
regulators of the cell cycle, ribosomal biogenesis and
modulators of myogenic differentiation as genes that are
targeted by Yap. Exploring the molecular mechanism by which
Yap works, we found that Yap can bind Tead transcription
factors and co-activate MCAT-elements in myoblasts.
Results
Yap is highly expressed in activated satellite cells
We first investigated the expression of Yap during myogenic cell
fate progression of satellite cells using immunocytochemistry. To
this end we cultured satellite cells ex vivo in their niche on muscle
fibres isolated from mouse (Mus musculus) extensor digitorum
longus muscle (Collins and Zammit, 2009; Zammit et al., 2004). In
quiescent satellite cells (Pax7-positive cells at 0 h) the Yap signal
was low and comparable to that seen in the adjacent fibre (Fig. 1A).
During satellite cell activation, Yap protein increased and Yap was
robustly expressed in activated, MyoD+ satellite cells (24 h and
48 h) (Fig. 1B). It remained highly expressed in clusters of satellite
cells at 72 h, both in differentiating, myogenin-positive cells and
also in Pax7-positive cells. The continued expression of Pax7 at
72 h in satellite cell progeny suggests that these cells are entering
the self-renewal pathway (Zammit et al., 2004) (Fig. 1C,D).
To quantify Yap gene expression during satellite cell
activation we removed satellite cells by trypsin digestion from
ex vivo cultured muscle fibres at 0 h, 48 h and 72 h and measured
Yap mRNA using quantitative RT-PCR. We found that Yap
mRNA increased significantly <2.6-fold from 0 h to 48 h to
72 h (Fig. 1E; supplementary material Fig. S1). The low level of
Fig. 1. Yap is highly expressed in activated satellite cells until after the
differentiation versus self-renewal decision is made. (A–D) Sets of three
example images in one row. (A) Low Yap expression in a Pax7+ satellite cell at
0 h of ex vivo culture. (B) Yap is highly expressed in all activated, MyoD+
satellite cells at 48 h. (C) Yap is highly expressed in satellite cells that still
express Pax7 after 72 h and some adjacent cells. (D) Yap is also highly
expressed in myogenin+, differentiating cells and again in some adjacent cells
after 72 h. (E) Yap mRNA in satellite cells trypsin-digested from ex vivo
cultured fibres increases significantly <2.6-fold from 0 h to 48 h and is still
highly expressed at 72 h (ANOVA, P,0.01; n53 each; for MyoD expression,
see supplementary material Fig. S1). (F) Yap mRNA decreases significantly by
<2.3–3.2-fold in plated satellite cell-derived myoblasts during differentiation
(ANOVA, P,0.01; n54 each apart from 48 h which is n53; mean6s.d.).
Time points 6–48 h are all significantly different from 0 h (for Myf5 and
myogenin expression, see supplementary material Fig. S1). Scale bar: 50 mm.
Journal of Cell Science 125 (24)6010
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Yap in quiescent satellite cells and in muscle fibres implies that
Yap is downregulated in both differentiating and self-renewing
satellite cells. To obtain further evidence for the downregulation
of Yap during differentiation we measured Yap mRNA in
plated satellite cell-derived myoblasts that were triggered to
differentiate by culture in mitogen-low differentiation medium.
We observed a significant, <2.3–3.2-fold decrease of Yap
mRNA from 6 h to 48 h after differentiation was induced
(Fig. 1F) and a significant, <1.6–1.9-fold decrease of Yap
protein (supplementary material Fig. S1).
Previous studies have demonstrated that Yap is controlled in
part through phosphorylation at Ser127 which decreases its
activity. In differentiating satellite cell-derived myoblasts,
Yap Ser127 phosphorylation relative to total Yap increased
significantly 2.1–2.5-fold after 24 h and 48 h of differentiation
when compared to proliferating myoblasts, respectively
(supplementary material Fig. S1). An increase of Yap Ser127
phosphorylation also occurs in differentiating C2C12 myoblasts
although the fold-change of phosphorylation is lower in
differentiating satellite cell-derived myoblasts (Watt et al.,
2010). To summarise, Yap mRNA and protein increases during
satellite cell activation and Yap remains elevated until activated
cells differentiate or self-renew. During differentiation Yap mRNA
and protein decreases whilst Yap Ser127 phosphorylation
increases which together act to reduce the activity of Yap.
Yap expression and activity promotes proliferation of
satellite cells and satellite cell-derived myoblasts
Yap has been previously shown to regulate the proliferation of
several types of adult stem cells. To investigate whether Yap has a
comparable function in satellite cells we carried out both gain- and
loss-of-function experiments. Yap was constitutively expressed in
both plated satellite cell-derived myoblasts and muscle fibre-
associated satellite cells via retroviral mediated delivery. For this
wild-type hYAP1 and constitutively active hYAP1 S127A were
cloned into modified pMSCV, where an IRES-eGFP marks
infected cells. This allowed Yap dose-response analyses as hYap1
S127A increases the luciferase activity of an MCAT element-
driven luciferase reporter more than wild-type hYAP1 which in
turn increases luciferase activity more than the empty vector
(Fig. 7A) which served as a negative control (Fig. 2A).
Proliferation was assessed by ethynyldeoxyuridine (EdU)
or iododeoxyuridine (IdU) incorporation and scored as the
percentage of GFP-positive nuclei that additionally contained
EdU or IdU, respectively. We found that constitutive expression
of hYAP1 S127A but not wild-type hYAP1 significantly
increased the proliferation of satellite cells cultured ex vivo by
75% when compared to the empty vector control (Fig. 2B,C,F). In
plated satellite cell-derived myoblasts overexpression of wild-
type hYAP1 significantly increased proliferation by 53% and
overexpression of hYAP1 S127A increased proliferation by 79%
against empty vector control, respectively (Fig. 2D,E,F).
Enhanced proliferation signalling was supported by the finding
that the concentration of the proliferation marker PCNA was
higher in hYAP1 and hYAP1 S127A expressing cells than in the
empty vector control (Fig. 2A).
Decreased Yap expression inhibits proliferation of satellite
cell-derived myoblasts
To test whether Yap is required for normal proliferation we
infected plated satellite cell-derived myoblasts with a lentivirus
delivering either anti-Yap shRNA or scrambled shRNA as a
Fig. 2. Effect of retrovirus-mediated constitutive expression
of wild-type hYAP1 or constitutively active hYAP1 S127A on
the proliferation of satellite cells. (A) Western blot of Yap
following retroviral delivery of hYAP1 and hYAP1 S127A
compared to empty vector negative control. (B–E) show sets of
representative images of EdU incorporation in muscle fibre-
associated satellite cells (B,C) and plated satellite cell-derived
myoblasts (D,E) following constitutive expression of hYAP1
S127A compared to control. (F) Quantification of the data (n53
for satellite cells cultured ex vivo, ANOVA: P50.01; n55 for
satellite cell-derived myoblasts; ANOVA: P,0.01; mean6s.d.).
Scale bars both 50 mm.
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control. Efficient knockdown was first validated by western blot
in C2C12 myoblasts (Fig. 3A). Infection of satellite cell-derived
myoblasts with anti-Yap shRNA significantly reduced
proliferation by <40% when compared to control myoblasts
infected with a scrambled shRNA control (Fig. 3C,D). Together
with the gain of function data these results show that high Yap
activity promotes satellite cell proliferation whereas lowering the
normal concentration of Yap in satellite cell-derived myoblasts
decreases proliferation. This suggests that the normal increase of
the Yap concentration during satellite cell activation drives the
proliferation of activated satellite cells.
High Yap expression inhibits terminal differentiation
To investigate the effect of high levels of Yap expression and
activity on the fate of satellite cells we again overexpressed either
wild-type hYAP1 or hYAP1 S127A together with eGFP in
satellite cells cultured in their niche ex vivo using retroviral
infection. We then quantified the expression of the satellite cell
fate markers Pax7, MyoD and myogenin in all eGFP-positive
cells. After 72 h in culture, overexpression of wild-type hYAP1
and hYAP1 S127A significantly increased the number of Pax7-
positive cells by 82% and 111% (Fig. 4A,B,E) but reduced
differentiating, myogenin-positive cells significantly by 35% and
52%, respectively, when compared to empty vector controls
(Fig. 4C,D,E). The number of MyoD-positive cells was
unaffected (Fig. 4E; supplementary material Fig. S2). Together
with the results shown in Figs 2 and 3 this suggests indirectly that
high Yap expression and activity expands the pool of activated
(Pax+, MyoD+) satellite cells but impairs differentiation.
High Yap expression and activity impairs myogenic
differentiation
To specifically determine the effect of high levels of Yap
expression and activity on myogenic differentiation we
constitutively expressed wild-type hYAP1 or hYAP1 S127A in
plated satellite cell-derived myoblasts and again compared them
to empty vector negative controls. We induced differentiation by
shifting from a mitogen-rich to a mitogen-low medium. In this
model, wild-type hYAP1 and hYAP1 S127A overexpression
reduced myogenic fusion (i.e. the percentage of nuclei found in
myosin heavy chain-positive cells) significantly by 18% and 50%
when compared to empty vector, respectively (Fig. 5A–D).
Moreover, hYAP1 and hYAP1 S127A overexpression reduced
the expression of the late differentiation regulator myogenin
significantly by 21% and 38% but increased the percentage of
Pax7-positive cells significantly by 42% and 85%, respectively
(Fig. 5A–D). This confirms that high Yap expression and activity
Fig. 3. Effect of Yap knockdown by lentiviral shRNA infection on the
proliferation of satellite cell-derived myoblasts. (A) C2C12 myoblasts were
infected with two anti-Yap shRNAs (shRNA A, shRNA B) and Yap protein
was measured. shRNA B was chosen for subsequent experiments as it
knocked down Yap protein by 72% in C2C12 myoblasts. (B) Effect of either
scrambled RNA or (C) anti-Yap shRNA on IdU+ nuclei in satellite cell-
derived myoblasts. (D) Anti-Yap shRNA B treatment reduces proliferation by
<40% (t-test; mean6s.d.). Scale bar: 50 mm.
Fig. 4. Effect of retroviral overexpression of empty vector,
wild-type hYAP1 (supplementary material Fig. S2) or
constitutively active hYAP1 S127A on the expression of the
cell fate markers Pax7, MyoD (supplementary material Fig.
S2) and myogenin in satellite cells cultured in their niche ex
vivo. (A–D) Sets of three images in a column. The images are
examples for muscle fibres that were quantified.
(E) Quantitative analysis. For Pax7 and myogenin, the
differences between groups are significant (the fibres from n53
muscles per group were quantified; ANOVA: P,0.01;
mean6s.d.). Scale bar: 50 mm.
Journal of Cell Science 125 (24)6012
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prevents differentiation and indirectly suggests that it expands the
pool of activated satellite cells.
Next we tested whether lentiviral shRNA knockdown of
Yap affected myogenic differentiation. The data in Fig. 6 show
that myogenic differentiation is not effected by a decreased
concentration of Yap probably because Yap activity is already
downregulated at this point so that a further reduction does not
significantly affect differentiation.
Yap regulates the expression of genes associated with the
cell cycle, ribosome biogenesis and terminal myogenic
differentiation
In order to elucidate some of the mechanisms responsible for the
phenotype induced by Yap we conducted an expression
microarray analysis. Because high Yap activity inhibits
terminal differentiation (Figs 4, 5) we chose short periods of
hYAP1 S127A overexpression (20 h and 40 h of hYAP1 S127A
induction by doxycycline) in order to identify especially those
genes that are directly targeted by Yap and/or have a regulatory
function rather than just comparing the transcriptome of
differentiated myotubes versus myoblasts that have not
differentiated because of high Yap activity. Myoblasts were
obtained from Myf5-Cre Col1aTetOP-hYAP1 S127A/+ R26stop-RtTA/+
mice after purification by pre-plating. The overexpression of
hYAP1 S127A was induced in Myf5-expressing myoblasts for
20 h or 40 h by doxycycline treatment and these myoblasts were
compared to untreated myoblasts. Doxycycline treatment induced
robust hYAP1 S127A overexpression (Fig. 7A). The numbers of
genes that were upregulated or downregulated in response to
20 h, 40 h or both 20 h and 40 h doxycycline treatment are
shown in Fig. 7B. The complete set of genes that responded to
overexpression of hYAP1 S127A with a more than 1.3-fold
change either up or down (P,0.05) is shown in supplementary
material Table S1.
To test in a non-biased way whether the genes upregulated by
hYAP1 S127A overexpression were significantly associated
with a particular GOBP (gene ontology biological process) we
analysed our data set using Gene Set Enrichment Analyses
(GSEA; see Materials and Methods). Consistent with the pro-
proliferation phenotype that is induced by high Yap activity, this
analysis identified significant upregulation of genes that are
linked to 17 gene ontology (GO) lists linked to the cell cycle
(Fig. 7C; supplementary material Table S2). Additionally we
found upregulation of genes linked to ribosomal biogenesis and
rRNA metabolism and significant downregulation of genes
linked to G-protein-linked signalling processes (Fig. 7C;
supplementary material Table S2).
We also searched the list of genes that responded to hYAP1
S127A overexpression at both 20 h and 40 h by conducting a
systematic Medline search using the additional search terms
‘skeletal muscle’, ‘satellite cells’ and ‘myogenesis’ as well as a
Swissprot search for the gene name. We then compiled a
selection of genes modulated by hYap1 S127A overexpression
Fig. 5. Effect of retroviral overexpression of wild-type hYAP1 or
constitutively active hYAP1 S127A on the expression of cell fate markers
(Pax7 and MyoD) and markers of myogenic fusion (myosin heavy chain)
in satellite cell-derived myoblasts cultured on Matrigel. (A–C) Sets of
three images displayed in one row. The images show that increased levels of
Yap activity (hYAP1 S127A .wild-type hYAP1 .empty vector) reduce the
proportion of nuclei found in differentiated, myosin heavy chain-positive
cells. Similar sets of example images for Pax7 and myogenin are shown in
supplementary material Fig. S3. (D) Quantitative analysis. Increasing levels
of Yap activity significantly increase Pax7 expression (P,0.01), but decrease
myogenin (P,0.01) and myosin heavy chain expression (the fibres from n53
muscles per group were quantified; ANOVA: P,0.01; mean6s.d.). Scale bar:
50 mm.
Fig. 6. No effect of lentivirus-mediated Yap knockdown on the
differentiation of satellite cell-derived myoblasts. (A,B) Sets of three
example images per row showing the effect of Yap knockdown by lentiviral
delivered shRNA when compared to empty vector negative control. Similar
sets of example images for Pax7 and myogenin are shown in supplementary
material Fig. S4. (C) Quantification of the Yap knockdown experiment. The
percentage of nuclei found in myosin heavy chain-positive myotubes or the
percentage of nuclei that stained positive for myogenin and Pax7 was
quantified (the fibres from n53 muscles per group were quantified; ANOVA:
P,0.01; mean6s.d.). Scale bar: 50 mm.
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and whose known function might potentially explain important
aspects of the observed pro-proliferation, anti-differentiation
phenotype that is induced by high Yap activity (Fig. 7D).
Next we tested whether Yap could regulate gene expression
by co-activating MCAT elements and by binding to Tead
transcription factors in myoblasts as has been reported for
other cell types. We found that hYAP1 and hYAP1 S127A
overexpression significantly increased the activity of a luciferase
reporter driven by 8 MCAT elements (8XGTIIC-luciferase) by
3.6-fold and 5-fold, respectively. In contrast, knockdown of Yap
by shRNA reduced the activity of the reporter by 61% (Fig. 7E).
We also confirmed by immunoprecipitation that Yap can bind
Tead1 in myoblasts (Fig. 7F). These experiments demonstrate
that Yap can both activate MCAT elements and bind to Tead
transcription factors in myoblasts. Because of this analysis and
because Yap and Tead have been reported to bind in<80% of the
cases to the promoter of the same genes in MCF10A cells (Zhao
et al., 2008) we tested for an overlap between genes upregulated
by both 20 h and 40 h of doxycycline in our study and genes
whose promoters were reported to be occupied by either Tead1 in
adult skeletal muscle (Qiu et al., 2011) or by Tead4 in C2C12
myoblasts (Benhaddou et al., 2012) (supplementary material
Table S3). These analyses reveal an overlap of 3 genes with the
Tead1-occupied genes in adult skeletal muscle and of 29 genes
with Tead4-occupied genes in C2C12 myoblasts. Because Yap is
capable of co-activating MCAT elements in myoblasts (Fig. 7E),
we also analysed the set of genes that responded to both 20 h and
40 h of doxycycline treatment for MCAT elements in the
proximal promoter (22 kb to +2 kb) relative to the transcription
start site using the Transfac matrix for Tead1 (i.e. MCAT
elements) (supplementary material Table S3). This analysis
identified 13 genes (9.4%) with putative MCAT elements among
the 138 upregulated genes which represents a significant
enrichment of MCAT elements (P,0.01).
Discussion
Our data demonstrate for the first time an important function for
the Hippo pathway member Yap in the regulation of satellite cell
fate. Yap promotes the proliferation of activated satellite cells
whilst inhibiting their differentiation. Consistent with the cellular
phenotype, Yap regulates the expression of genes associated with
the cell cycle, ribosome biogenesis, angiotensin signalling and
myogenic differentiation.
Yap mRNA and protein increase during satellite cell activation
and Yap remains highly expressed until after the differentiation
versus self-renewal decision is made (Fig. 1). A similar decrease
of Yap expression during differentiation has been reported for
embryonal and neuronal stem cells (Lian et al., 2010; Zhang et al.,
2012) suggesting that a decline of Yap expression during
differentiation is not restricted to satellite cells. The increase of
Yap during satellite cell activation and decline during
differentiation is at least partially due to a decreased expression
of Yap mRNA (Fig. 1E,F). In this study we have not tested
whether some of the decline of Yap protein levels is due to
Yap ubiquitination and degradation triggered by Ser381
phosphorylation (Zhao et al., 2010) as the Yap Ser381 antibody
was not available to us.
Yap mRNA and protein not only declines during
differentiation but the phosphorylation of the remaining Yap at
Ser127 increases significantly at the onset of differentiation
(supplementary material Fig. S1). As a consequence, Yap activity
should be markedly decreased at the onset of differentiation as
there is both less Yap protein and that that is there is less active
due to increased, inhibitory Ser127 phosphorylation. In C2C12
Fig. 7. Gene expression response to hYAP1 S127A
overexpression in myoblasts, Yap binding to Tead1 and co-
activation of MCAT elements by Yap. (A) Effect of 20 h and
40 h of doxycycline treatment on hYAP1 expression (n53,
ANOVA). (B) Venn diagram displaying the numbers of genes
that changed their expression after 20 h, 40 h or both 20 h and
40 h of doxycycline treatment versus control (total; up,
upregulated; down, downregulated). (C) Gene ontology (GO)
terms enriched among 20 h and 40 h doxycycline-responsive
genes that were either up- or downregulated. (D) Fold
expression changes for individual genes after 20 h (black bars)
and 40 h (white bars) of doxycycline treatment versus no
doxycycline control. (E) Wild-type hYAP1 and constitutively
active hYAP1 S127A increase the activity of an MCAT-driven
luciferase promoter whilst Yap knockdown with shRNA (see
Fig. 3 for the validation of the knockdown) reduces its activity
in C2C12 myoblasts. (F) Yap binds to Tead1 in C2C12
myoblasts as demonstrated by immunoprecipitation. IP,
immunoprecipitation; IB, immunoblot.
Journal of Cell Science 125 (24)6014
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myoblasts Ser127 phosphorylation increases ,20-fold at the
onset of differentiation but in contrast to satellite cell-derived
myoblasts, the total concentration of Yap remains similar during
differentiation (Watt et al., 2010) highlighting a difference
between differentiating satellite cells and C2C12 myoblasts.
In activated satellite cells, high levels of Yap expression and
activity promote proliferation (Fig. 2) whilst Yap knockdown
reduces proliferation (Fig. 3). This is comparable to what we
have previously reported for C2C12 myoblasts (Watt et al., 2010)
and matches findings reported for other adult stem and progenitor
cells such as intestinal stem cells (Camargo et al., 2007), hepatic
oval cells (Lee et al., 2010), neural stem cells (Cao et al., 2008)
and epidermal stem cells (Schlegelmilch et al., 2011). Thus Yap
appears to be capable of generally expanding adult stem and
progenitor cell populations. High Yap expression and activity
also retains satellite cells in their activated state and prevents
their differentiation (Figs 4, 5) as judged by the high expression
of Pax7 and MyoD and decreased expression of myogenin in
satellite cells where the activity of Yap has been increased by
retroviral-mediated constitutive expression of hYAP1 S127A. A
reduction of Yap protein by shRNA mediated knockdown at the
onset of differentiation does not affect the progression of
differentiation (Fig. 6) presumably because Yap expression and
activity is already sufficiently downregulated. Thus, high Yap
expression and activity expands the pool of activated satellite
cells and prevents the differentiation of this cell population.
In order to identify the underlying molecular mechanisms, we
conducted an expression microarray analysis in myoblasts where
hYAP1 S127A expression was induced by 20 h and 40 h of
doxycycline treatment versus untreated controls (Fig. 7A). We
focussed our analyses on the 271 genes that were responsive to
both 20 h and 40 h of doxycycline treatment. Additionally 52 and
682 genes responded only to either 20 h or 40 h of doxycycline
treatment, respectively (Fig. 7B). We found that after 40 h the
terminal differentiation markers Myh4 (myosin heavy chain IIb)
and CKM (muscle creatine kinase) were significantly
downregulated in the doxycycline treated myoblasts
(supplementary material Table S1). This suggests that terminal
differentiation had started after 40 h in the untreated myoblasts
whilst hYAP1 S127A overexpression prevented this, resulting in
a lower expression of terminal differentiation markers in the
hYAP1 S127A overexpressing cells.
To determine whether the genes modulated by hYAP1 S127A
overexpression were significantly enriched for a particular
biological process, we performed GOBP (gene ontology
biological process) and GSEA (gene set enrichment analysis)
analyses for genes that responded to both 20 h and 40 h of
doxycycline treatment. These analyses revealed significant
upregulation of many cell cycle-related genes (Fig. 7C;
supplementary material Table S2) which matches the pro-
proliferation phenotype that is induced by high Yap activity
(Figs 2, 3). The responsive cell cycle-related genes include
cyclins, cyclin-related kinases, cell cycle checkpoint-regulating
genes and genes that modulate other aspects of the cell cycle such
as cytokinesis. There is emerging evidence that the promoters of
at least some cell cycle-regulating genes are directly targeted by
Yap (Mizuno et al., 2012). We also found an upregulation of
genes associated with ribosome biogenesis and rRNA
metabolism (supplementary material Table S2). This again
matches the pro-proliferation phenotype induced by Yap
because ribosome biogenesis is required for cell cycle
progression as ribosome stress will trigger cell-cycle arrest via
a mechanism that involves p53 (Lempia¨inen and Shore, 2009).
Interestingly, G-protein coupled receptor protein signalling
genes were downregulated. This group includes ACE
(angiotensin-converting enzyme), Bdkrb1 (bradykinin receptor,
b1), RGS2/5 (regulator of G-protein signalling 2 and 5) and Gem
(GTP binding protein; gene overexpressed in skeletal muscle)
(supplementary material Table S2). These genes can be linked to
the angiotensin pathway which has recently been associated with
satellite cell function (Johnston et al., 2010). Recently it has been
demonstrated that the Hippo pathway is regulated G-protein-
coupled receptor signalling (Yu et al., 2012) and it is intriguing
that high Yap activity transcriptionally inhibits several members
of this pathway in myoblasts.
Next we compiled a list of candidate genes that were
responsive to hYAP1 S127A overexpression and which could
explain aspects of the phenotype induced by high Yap activity
(Fig. 7D). Overexpression of hYAP1 S127A increased the
expression of three Hippo signal transduction pathway genes at
both 20 h and 40 h that have been reported to inhibit Yap
activity. They are Willin/Frmd6 (Angus et al., 2012),
angiomotin-like 2 (amotl2) (Zhao et al., 2011) and ajuba (Das
Thakur et al., 2010). After 40 h of doxycycline treatment another
putative Yap inhibitor and Hippo pathway member, WWc2 [WW
and C2 domain containing 2; kibra homologue (Yoshihama et al.,
2012)], is additionally upregulated. The upregulation of these
Yap inhibitors by high Yap activity is potentially important
because Yap is an oncogene and this negative feedback loop
might limit the intensity and duration of Yap signalling.
The next group of genes that is responsive to hYAP1 S127A
overexpression are three growth factors that can be linked to
satellite cells and/or myogenesis. Of these, connective tissue
growth factor (CTGF) has been extensively characterised as a
Yap/Tead-responsive gene by ChIP-Seq and Yap/Tead gain and
loss-of-function experiments (Zhao et al., 2008). CTGF has three
MCAT elements in the proximal promoter which was confirmed
by our analysis (supplementary material Table S3). CTGF is
highly expressed in dystrophic muscle (Sun et al., 2008) which
contains a high proportion of activated and proliferating satellite
cells (Pallafacchina et al., 2010). Thus the high expression of
CTGF may be due to the high Yap activity in activated satellite
cells (Fig. 1). Nerve growth factor (NGF) was shown to inhibit
the differentiation of muscle-derived stem cells (Lavasani et al.,
2006), which matches the function of Yap reported in this study.
Hepatocyte growth factor (HGF) is downregulated by hYAP1
S127A overexpression. HGF was identified as a factor capable of
activating satellite cells (Tatsumi et al., 1998) and thus the
downregulation of HGF by Yap would be counterintuitive.
However, a more recent study has suggested that high
concentrations of HGF promote satellite cell quiescence
(Yamada et al., 2010) and therefore the effect of the
downregulation of HGF by Yap is difficult to interpret (Fig. 1).
TGFb and BMP signalling has been associated with muscle
growth and satellite cell function. In our analysis BMP4 (bone
morphogenetic protein 4) and Fstl3 (follistatin-related protein 3)
increased their expression in response to hYap1 S127A
overexpression. Exogenous BMP4 was reported to promote
satellite cell proliferation and inhibit differentiation (Ono et al.,
2011) which is consistent with the function of Yap. Fstl3 inhibits
myostatin via its N-terminal domain (Cash et al., 2012). Because
myostatin inhibits satellite cell activation and re-entry into the
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cell cycle (McCroskery et al., 2003), the increase expression of
Fstl3 is consistent with satellite cell activation and proliferation
due to myostatin inhibition by Fstl3.
Next we identified a diverse group of regulators of myogenesis
and/or proliferation whose expression pattern and/or function
matches the phenotype induced by hYAP1 S127A
overexpression. Muscleblind-like 3 (MBNL3) is, like Yap,
highly expressed in myoblasts but not in differentiated muscle
and it inhibits differentiation of C212 myoblasts (Lee et al.,
2008). PEA-15 (phosphoprotein enriched in astrocytes 15A)
overexpression in myoblasts prevents, like high levels of Yap
activity, their differentiation (Iovino et al., 2012). CD34 is a cell
surface protein marker found, among others, on satellite cells. It
has recently been reported that CD34 promotes re-entry into the
cell cycle after injury (Alfaro et al., 2011; Beauchamp et al.,
2000), which is consistent with the phenotype induced by Yap. In
this group, several genes were downregulated by hYAP1 S127A
overexpression. NDRG2 (N-myc downstream regulated gene 2)
is highly expressed in differentiated myotubes and little in
myoblasts but promotes proliferation (Foletta et al., 2009), which
is not consistent with the pro-proliferation effect of Yap.
However, the high expression of NDRG2 in post-mitotic
myotubes and its positive effect on proliferation is
contradictory. Like NDRG2, Myf6 (Mrf4) is repressed by
hYAP1 S127A overexpression. Myf6 is a myogenic
determination gene (Kassar-Duchossoy et al., 2004) whose
expression increases, unlike that of MyoD and Myf5, late
during myogenic differentiation (Tomczak et al., 2004). This
involves an involvement in terminal differentiation. The
repression of Myf6 by Yap may inhibit these effects. Fbox32
(atrogin-1; Mafbx) is a skeletal muscle atrophy-regulator (Sandri
et al., 2004) and has been implicated in the degradation of MyoD
(Tintignac et al., 2005). The downregulation of Fbox32
expression by high Yap activity in activated satellite cells may
contribute to sustaining high levels of MyoD in activated satellite
cells. Taken together, this list of candidate genes may represent
important downstream targets of Yap that regulate aspects of the
phenotype that is induced by high Yap activity in satellite cells
and myoblasts.
In order to gain some insight into how Yap regulates gene
expression we focussed on the hypothesis that Yap binds to Tead
transcription factors to co-activate MCAT elements. We found
that hYAP1 and hYAP1 S127A could activate an 8xGTIIc-
luciferase reporter whereas knockdown of Yap by shRNA
reduced it (Fig. 7E). The 8xGTIIc-luciferase reporter is
described as a Yap/Taz-activity reporter (Dupont et al., 2011),
which is driven by 8 MCAT elements obtained from the genome
of the SV40 polyomavirus. Such MCAT elements are targeted by
Tead transcription factors (Yoshida, 2008) and thus in our
experiment Yap was most likely co-activating the MCAT
elements of the reporter by binding to the Tead isoforms
present in myoblasts. Next we performed a Yap-Tead1
immunoprecipitation experiment which confirmed that Yap can
bind to Tead transcription factors in myoblasts (Fig. 7F). This is
in line with previous results that have demonstrated that Yap can
bind to all four Tead transcription factors in non muscle cells and
that Yap and Tead1 occupy the same promoter in <80% of the
cases in MCF10A cells (Vassilev et al., 2001; Zhao et al., 2008).
Based on the ability of Yap to co-activate MCAT elements and
to bind to Teads in myoblasts, we tested for an overlap between
genes that were induced by both 20 h and 40 h of doxycycline
and genes whose promoters were reported to be occupied either
by Tead1 in adult skeletal muscle (Qiu et al., 2011) or by Tead4
in C2C12 myoblasts (Benhaddou et al., 2012). This analysis
revealed an overlap of 3 genes with the Tead1-occupied genes in
adult skeletal muscle and of 29 genes with Tead4-occupied genes
in C2C12 myoblasts (supplementary material Table S3). This is
indirect evidence that Yap, Tead1 and Tead4 bind to and induce
the expression of at least some genes. The low overlap with
Tead1-occupied genes in adult skeletal muscle can be partially
explained by the fact that only 138 genes were identified in the
Tead1 ChIP-on-Chip analysis and that the analysis was
performed on adult skeletal muscle rather than in myoblasts
(Qiu et al., 2011). Unfortunately, no genome-wide Tead2 and
Tead3 binding data are currently available for myoblasts which
limits this analysis.
Next we probed for enrichment of MCAT elements (Transfac
matrix for Tead1/Tef) in the proximal promoters (22 kb to +2 kb
relative to the transcription start site) of genes whose expression
increased after 20 h and 40 h of doxycycline treatment. We
found that 13 out of 138 genes (9.4%) had putative MCAT
elements in their proximal promoters which represents a
significant enrichment (P,0.01) among the genes upregulated
after both 20 h and 40 h of doxycycline treatment
(supplementary material Table S3). Whilst this is a significant
enrichment, it is still a low percentage. There are two possible
explanations. First, some of the genes that responded to
doxycycline treatment may only be indirectly regulated by
Yap. Second, some genes that are directly targeted by Yap may
have MCAT elements in enhancers that are located outside the
proximal promoter. Evidence for distant enhancers comes from
genome-wide searches for regulatory elements. Such studies have
revealed for example that much of the tissue-specific regulation
of gene expression depends on distant enhancers rather than
proximal promoters (Cao et al., 2010; Heintzman et al., 2009).
In conclusion, Yap expression increases during satellite cell
activation and Yap remains highly expressed until after the
differentiation versus self-renewal decision is made. High Yap
levels and activity expands the pool of activated satellite cells
and prevents differentiation by activating genes associated with
the cell cycle, ribosome biogenesis angiotensin signalling and
genes that maintain the activated satellite cell or myoblast
phenotype and/or inhibit differentiation.
Materials and Methods
Muscle fibre isolation and satellite cell culture
To study muscle fibre associated satellite cells ex vivo, viable single muscle fibres
were isolated from mouse EDL muscles following collagenase I digestion and
cultured in suspension as previously described (Collins and Zammit, 2009).
Isolated fibres were maintained in muscle fibre medium (DMEM-glutamax with
10% v/v horse serum, 0.5% v/v chick embryo extract and pen-strep) for up to 72 h
and then fixed in 4% PFA for 10 min at 0–72 h. For adherent satellite cell-derived
myoblasts, freshly isolated muscle fibres were plated onto dishes coated with
1 mg.ml21 of Matrigel (BD Biosciences) and incubated in proliferation medium
(DMEM-glutamax with 30% v/v foetal calf serum, 10% v/v horse serum, 1% v/v
chick embryo extract, 10 ng.ml21 of basic fibroblast growth factor and pen-strep).
After 72 h, muscle fibres were manually removed and re-seeded for further
expansion. For differentiation assays satellite cell-derived myoblasts were seeded
at high density and placed in differentiation medium (DMEM-glutamax with 2% v/
v horse serum and pen strep) for at least 48 h. For assays involving
immunofluorescent analysis satellite cells were seeded into 8 well chamber
slides (Lab-tek) and fixed in 4% PFA for 10 min.
RNA extraction, cDNA synthesis and quantitative RT-PCR
The mRNA expression of genes from muscle fibre associated satellite cells was
assessed using previously described protocols (Gnocchi et al., 2009). Briefly,
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single muscle fibres were stripped of their satellite cells via digestion in 0.125%
Trypsin-EDTA at 37 C˚ for 15 min followed by gentle trituration to release cells.
Fibre fragments were removed by passing medium through a 40 mm cell strainer
(BD Falcon). Cells were collected by centrifugation and washed twice with PBS.
The RNA from these cells or satellite cell-derived myoblasts was isolated using
commercial reagents (RNeasy Qiagen or Trizol, Invitrogen) and reverse
transcribed into cDNA using 100–400 ng of RNA (Quanti-Tect kit, Qiagen or
iScript cDNA kit, Bio-Rad). For plated cultures, cells were washed twice in PBS
and then RNA isolated using the same procedures as described above.
Quantitative RT-PCR was performed on an Mx3005P QPCR system
(Stratagene) with MESA Blue qPCR MasterMix Plus and ROX reference dye
(Eurogentec). Alternatively, a StepOnePlusTM RT-PCR system with TaqMan-
based RT-PCR gene expression assays (Applied Biosystems) were used for mouse
and human YAP1 (Mm00494249_m1, HS00902712_g1) and the multiplex-
compatible Gapdh or 18S internal control probes (Applied Biosystems).
The following primers were designed using Primer blast (NCBI): Yap1, forward 59-
ACCCAAGGCTGGACCCTCGTT-39 and reverse 59-AGCATTTGCTGTGCTG-
GGATTGATA-39; MyoD, forward 59-AGCACTACAGTGGCGACTCA-39 and
reverse 59-GCTCCACTATGCTGGACAGG-39; Gapdh, forward 59-GTGAAG-
GTCGGTGTGAACG-39 and reverse 59-ATTTGATGTTAGTGGGGTCTCG-39.
Expression was normalised to Gapdh. Gene expression relative to mRNA levels
in control samples was calculated using the Pfaffl method (Pfaffl, 2001). Results
show quantitative RT-PCR data from at least three independent experiments.
Microarray analysis
The Myf5-Cre mouse strain (B6.129S4-Myf5tm3(cre)Sor/J) was obtained from Jax
and crossed with Rosa26-Stop-RtTA Col1a TetOP-hYAP1 S127A mice
(Schlegelmilch et al., 2011) to generate Myf5-Cre Col1aTetOP-hYAP1 S127A/+
R26stop-RtTA/+ mice, in which Myf5-expressing cells express hYAP1 S127A upon
doxycycline treatment. Primary myoblasts [also referred to as muscle-derived stem
cells (MDSCs) or slowly adherent cells (SACs)] were isolated from the hind limb
muscles of these mice using the preplating method described previously
(Gharaibeh et al., 2008). Myoblasts were then cultured on 0.2% gelatin-coated
surface in growth medium (Promocell, C-23160 containing 20% FBS) with
1 mg.ml21 doxycycline to induce hYAP1 S127A overexpression or without
doxycycline as control for 20 h or 40 h. Total RNA was isolated using RNeasy kit
(Qiagen) and 5 mg of total RNA was used for analyses. Triplicate microarray
analyses of hYAP1 S127A transgenic primary myoblasts were conducted at the
Molecular Genetics Core Facility (Children’s Hospital Boston) using Mouse Gene
1.0 ST Arrays (Affymetrix, Santa Clara, CA). The mean of expression data was
determined to identify genes with altered levels of expression in the hYAP1 S127A
overexpressing myoblasts (doxycycline-treated) versus non-treated at each time
point (20 h and 40 h) using RMA16 normalisation algorithm with the Genespring
12 software (Agilent). An adjusted p-value cut off of 0.05 and a relative fold
change cut off of 1.3 were used, and genes were classified by biological function
based on Gene Ontology annotation [Genespring 12, Gene Set Enrichment
Analysis (GSEA) at http://www.broadinstitute.org/gsea/index.jsp], National Center
for Biotechnology Information gene descriptions or UniprotKB annotations. We
additionally checked for overlap between genes identified as Tead1 (Qiu et al.,
2011) or Tead4 targets (Benhaddou et al., 2012) and genes that responded to
doxycycline treatment for both 20 h and 40 h using an overlap search (http://jura.
wi.mit.edu/bioc/tools/compare.php).
Retroviral and lentiviral expression vectors and transduction methods
Wild type hYAP1 and a constitutively active mutant hYAP1 S127A cDNA were
sub-cloned into a pMSCV-IRES-eGFP (Zammit et al., 2006) retroviral backbone
from plasmid DNA (Addgene plasmids 17790 and 17791) creating pMSCV-
hYAP1-IRES-eGFP and pMSCV-hYAP1 S127A-IRES-eGFP constructs. This
system allows the expression of hYAP1 or hYAP1 S127A as a bi-cistronic
message together with eGFP for the identification of infected cells. Empty vector
pMSCV-IRES-eGFP was used as a negative control. Retroviruses were packaged
in 293T cells using standard methods. To infect muscle fibre-associated satellite
cells muscle fibres were cultured for 24 h following isolation and then incubated in
diluted viral supernatant (1:5) until assayed. Plated satellite cells were infected by
incubation with diluted viral supernatant (1:5) supplemented with polybrene (4 mg/
ml) for 3–4 h before being rinsed in PBS and placed back into fresh proliferation
medium. Lentiviral vectors (pLKO.1) containing anti-sense oligonucleotides
targeted against mouse Yap mRNA (Lian et al., 2010) were used for Yap
knockdown experiments. For virus production, lentiviral vectors were co-
transfected with psPAX2 and pMD2.G packaging plasmids into 293T cells and
viral supernatant was recovered using standard methods. C2C12 and plated
satellite cells were infected via incubation in diluted viral supernatant (1:5) for 4 h.
24 h after infection, transduced cells were selected with medium supplemented
with 2 mg.ml21 of puromycin and assayed after at least 5 days.
Immunocytochemistry
Fixed single muscle fibres and plated satellite cells were permeabilised with 0.5%
(v/v) Triton X-100 in PBS for 6 min and blocked with 10% (v/v) goat serum and
10% (v/v) swine serum in PBS for 30 min to reduce non-specific antigen binding.
Primary antibodies were applied overnight at 4 C˚ and consisted of rabbit anti-Yap
(a gift from Maris Sudol), rabbit anti-phospho Yap Ser127 (Cell Signaling, no
9411), mouse anit-Pax7 (DSHB), mouse anti-MyoD (Dako, clone 5.8A), mouse
anti-Myogenin (DSHB, clone FD5), mouse anti-MyHC (DSHB, clone MF20) and
chicken anti-GFP (Abcam, ab13970). Species-specific fluorochrome-conjugated
secondary antibodies were then applied for 2 h at room temperature. After that
slides were mounted with Vectashield mounting medium which contains
100 ng.ml21 of DAPI (4,6-diamidino-2-phenylindole; Vector Laboratories).
Proliferation assays
Satellite cell proliferation was assessed by via EdU (5-ethynyl-29-deoxyuridine) or
IdU (Iododeoxyuridine) incorporation into DNA. Culture media were
supplemented with 10 mM of either EdU or IdU and cells were pulsed for 2–
4 h. For EdU assays, the Click-iTH EdU kit (Invitrogen) was used following the
manufacturer’s instructions. For IdU assays, cells were fixed in 4% PFA and
stained using a mouse monoclonal anti-IdU antibody (ab8955, 1:100, Abcam,
Cambridge, UK) diluted in 0.15 M NaCl containing DNase (Sigma–Aldrich).
Western blotting
Cells were lysed in RIPA buffer (Tris 50 mM, NaCl 150 mM, SDS 0.1%, Na-
Deoxycholate 0.5% and Triton-X 100 1%) supplemented with 50 mM of NaF,
0.5 mM of sodium orthovanadate, 1 mM of EDTA and a protease inhibitor
cocktail (Sigma). Whole cell lysates were then separated via SDS-PAGE
electrophoresis and transferred to a nitrocellulose membrane. Membranes were
probed with the following primary antibodies overnight at 4 C˚: rabbit anti-Yap (a
gift from Maris Sudol), rabbit anti-phospho Yap Ser127 (Cell Signalling, NO.
4911), mouse anti-MyHC (DSHB, clone MF20), mouse anti-a-tubulin (Sigma,
clone B-5-1-2), mouse anti-PCNA (Cell Signaling, no. 2586), chicken anti-GFP
(Abcam, ab13970) and Tead1. Primary antibodies were then visualised using
species-specific Alexa Fluor 488/555 labelled secondary antibodies (Invitrogen).
Bands were quantified using a Li-Cor Odyssey infrared imager.
Co-immunoprecipitation assays
Plated C2C12 myoblasts were lysed in immunoprecipitation (IP) lysis buffer
(50 mM Tris HCl, 150 mM NaCl, 50 mM NaF, 1% Triton X-100) supplemented
with 1 mM sodium orthovanadate, 0.5 mM EDTA and protease inhibitor cocktail
(Sigma). Total cell lysates were homogenised and spun at 13,000 g for 15 minutes
at 4 C˚. 500 mg of protein lysates were incubated with 15 ml protein G-agarose
beads for 1 hour at 4 C˚ to remove proteins that bind non-specifically. Each protein
lysate was then incubated with <3 mg of Yap antibody (gift from Maris Sudol) or
an equivalent amount of species matched IgG (rabbit) rotating overnight at 4 C˚.
50 ml of beads were then added to the lysate and antibody mixture and rotated for
2 h at 4 C˚. The beads were then recovered following centrifugation and washed 3
times in ice cold IP lysis buffer. The supernatant was removed using a 26 G needle
to minimise bead loss. Beads were then resuspended in 30 ml 26sample buffer and
prepared for western blot analysis as above.
MCAT luciferase reporter assay
C2C12 cells were seeded into 6 well plates and transduced with control, hYAP1
wild-type and hYAP1 S127A retroviruses. Cells were then co-transfected with
8xGTIIC-luciferase (MCAT-reporter) and Renilla construct using Lipofectamine
LTX (Invitrogen) following the manufacturer’s instructions. Twenty-four hours
post transfection, cells were lysed and Firefly/Renilla luciferase activity quantified
by luminescence using a Dual-LuciferaseH Reporter Assay System (Promega)
following the manufacturer’s instructions.
Acknowledgements
We would like to thank Dr Marius Sudol for providing a Yap
antibody, Dr Kun-Liang Guan for a lentivirus for the shRNA-
mediated knockdown of Yap and Dr. Stefano Piccolo for providing
the 8xGTIIC-luciferase (MCAT-reporter) construct. Peter S.
Zammit, Fernando D. Camargo and Henning Wackerhage are joint
senior authors for this paper.
Funding
This research was funded by an Oliver Bird PhD studentship to R.J.;
a Medical Research Council project grant [grant number 99477 to
H.W., P.S.Z., C.D.B.]; and by a grant by Tenovus Scotland [grant
number G11/05 to C.D.B., H.W.]; P.K. was supported by a Medical
Research Council Doctorial training grant awarded to King’s College
London; A.M.T. is recipient of a postdoctoral fellowship from the
Yap in satellite cells 6017
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
Canadian Institutes of Health Research (CIHR); R.B.W. was funded
by the Wellcome Trust [grant number 085137/Z/08/Z] and the Raine
Medical Research Foundation. Microarray studies were performed
by the Molecular Genetics Core Facility at Children’s Hospital
Boston supported by National Institutes of Health [grant numbers
NIH-P50-NS40828, NIH-P30-HD18655]. Deposited in PMC for
release after 6 months.
Supplementary material available online at
http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.109546/-/DC1
References
Alfaro, L. A., Dick, S. A., Siegel, A. L., Anonuevo, A. S., McNagny, K. M., Megeney,
L. A., Cornelison, D. D. and Rossi, F. M. (2011). CD34 promotes satellite cell
motility and entry into proliferation to facilitate efficient skeletal muscle regeneration.
Stem Cells 29, 2030-2041.
Angus, L., Moleirinho, S., Herron, L., Sinha, A., Zhang, X., Niestrata, M., Dholakia,
K., Prystowsky, M. B., Harvey, K. F., Reynolds, P. A. et al. (2012). Willin/FRMD6
expression activates the Hippo signaling pathway kinases in mammals and
antagonizes oncogenic YAP. Oncogene 31, 238-250.
Beauchamp, J. R., Heslop, L., Yu, D. S., Tajbakhsh, S., Kelly, R. G., Wernig, A.,
Buckingham, M. E., Partridge, T. A. and Zammit, P. S. (2000). Expression of
CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells.
J. Cell Biol. 151, 1221-1234.
Benhaddou, A., Keime, C., Ye, T., Morlon, A., Michel, I., Jost, B., Mengus, G. and
Davidson, I. (2012). Transcription factor TEAD4 regulates expression of myogenin
and the unfolded protein response genes during C2C12 cell differentiation. Cell Death
Differ. 19, 220-231.
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R. and
Brummelkamp, T. R. (2007). YAP1 increases organ size and expands undifferentiated
progenitor cells. Curr. Biol. 17, 2054-2060.
Cao, X., Pfaff, S. L. and Gage, F. H. (2008). YAP regulates neural progenitor cell
number via the TEA domain transcription factor. Genes Dev. 22, 3320-3334.
Cao, Y., Yao, Z., Sarkar, D., Lawrence, M., Sanchez, G. J., Parker, M. H.,
MacQuarrie, K. L., Davison, J., Morgan, M. T., Ruzzo, W. L. et al. (2010).
Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular
reprogramming. Dev. Cell 18, 662-674.
Cash, J. N., Angerman, E. B., Kattamuri, C., Nolan, K., Zhao, H., Sidis, Y.,
Keutmann, H. T. and Thompson, T. B. (2012). Structure of myostatin?follistatin-
like 3: N-terminal domains of follistatin-type molecules exhibit alternate modes of
binding. J. Biol. Chem. 287, 1043-1053.
Cerletti, M., Jurga, S., Witczak, C. A., Hirshman, M. F., Shadrach, J. L., Goodyear,
L. J. and Wagers, A. J. (2008). Highly efficient, functional engraftment of skeletal
muscle stem cells in dystrophic muscles. Cell 134, 37-47.
Chan, S. W., Lim, C. J., Chong, Y. F., Pobbati, A. V., Huang, C. and Hong, W.
(2011). Hippo pathway-independent restriction of TAZ and YAP by angiomotin.
J. Biol. Chem. 286, 7018-7026.
Collins, C. A. and Zammit, P. S. (2009). Isolation and grafting of single muscle fibres.
Methods Mol. Biol. 482, 319-330.
Collins, C. A., Olsen, I., Zammit, P. S., Heslop, L., Petrie, A., Partridge, T. A. and
Morgan, J. E. (2005). Stem cell function, self-renewal, and behavioral heterogeneity
of cells from the adult muscle satellite cell niche. Cell 122, 289-301.
Das Thakur, M., Feng, Y., Jagannathan, R., Seppa, M. J., Skeath, J. B. and
Longmore, G. D. (2010). Ajuba LIM proteins are negative regulators of the Hippo
signaling pathway. Curr. Biol. 20, 657-662.
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M.
F., Anders, R. A., Maitra, A. and Pan, D. (2007). Elucidation of a universal size-
control mechanism in Drosophila and mammals. Cell 130, 1120-1133.
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M.,
Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S. et al. (2011). Role of YAP/
TAZ in mechanotransduction. Nature 474, 179-183.
Foletta, V. C., Prior, M. J., Stupka, N., Carey, K., Segal, D. H., Jones, S., Swinton,
C., Martin, S., Cameron-Smith, D. and Walder, K. R. (2009). NDRG2, a novel
regulator of myoblast proliferation, is regulated by anabolic and catabolic factors.
J. Physiol. 587, 1619-1634.
Gharaibeh, B., Lu, A., Tebbets, J., Zheng, B., Feduska, J., Crisan, M., Pe´ault, B.,
Cummins, J. and Huard, J. (2008). Isolation of a slowly adhering cell fraction
containing stem cells from murine skeletal muscle by the preplate technique. Nat.
Protoc. 3, 1501-1509.
Gnocchi, V. F., White, R. B., Ono, Y., Ellis, J. A. and Zammit, P. S. (2009). Further
characterisation of the molecular signature of quiescent and activated mouse muscle
satellite cells. PLoS ONE 4, e5205.
Halder, G., Polaczyk, P., Kraus, M. E., Hudson, A., Kim, J., Laughon, A. and
Carroll, S. (1998). The Vestigial and Scalloped proteins act together to directly
regulate wing-specific gene expression in Drosophila. Genes Dev. 12, 3900-3909.
Harvey, K. and Tapon, N. (2007). The Salvador-Warts-Hippo pathway - an emerging
tumour-suppressor network. Nat. Rev. Cancer 7, 182-191.
Heallen, T., Zhang, M., Wang, J., Bonilla-Claudio, M., Klysik, E., Johnson, R. L.
and Martin, J. F. (2011). Hippo pathway inhibits Wnt signaling to restrain
cardiomyocyte proliferation and heart size. Science 332, 458-461.
Heintzman, N. D., Hon, G. C., Hawkins, R. D., Kheradpour, P., Stark, A., Harp,
L. F., Ye, Z., Lee, L. K., Stuart, R. K., Ching, C. W. et al. (2009). Histone
modifications at human enhancers reflect global cell-type-specific gene expression.
Nature 459, 108-112.
Iovino, S., Oriente, F., Botta, G., Cabaro, S., Iovane, V., Paciello, O., Viggiano, D.,
Perruolo, G., Formisano, P. and Beguinot, F. (2012). PED/PEA-15 induces
autophagy and mediates TGF-beta1 effect on muscle cell differentiation. Cell Death
Differ. 19, 1127-1138.
Johnston, A. P., Baker, J., Bellamy, L. M., McKay, B. R., De Lisio, M. and Parise,
G. (2010). Regulation of muscle satellite cell activation and chemotaxis by
angiotensin II. PLoS ONE 5, e15212.
Kassar-Duchossoy, L., Gayraud-Morel, B., Gome`s, D., Rocancourt, D.,
Buckingham, M., Shinin, V. and Tajbakhsh, S. (2004). Mrf4 determines skeletal
muscle identity in Myf5:Myod double-mutant mice. Nature 431, 466-471.
Lavasani, M., Lu, A., Peng, H., Cummins, J. and Huard, J. (2006). Nerve growth
factor improves the muscle regeneration capacity of muscle stem cells in dystrophic
muscle. Hum. Gene Ther. 17, 180-192.
Lee, K. P., Lee, J. H., Kim, T. S., Kim, T. H., Park, H. D., Byun, J. S., Kim, M. C.,
Jeong, W. I., Calvisi, D. F., Kim, J. M. et al. (2010). The Hippo-Salvador pathway
restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc. Natl.
Acad. Sci. USA 107, 8248-8253.
Lee, K. S., Smith, K., Amieux, P. S. and Wang, E. H. (2008). MBNL3/CHCR prevents
myogenic differentiation by inhibiting MyoD-dependent gene transcription.
Differentiation 76, 299-309.
Lempia¨inen, H. and Shore, D. (2009). Growth control and ribosome biogenesis. Curr.
Opin. Cell Biol. 21, 855-863.
Lepper, C., Partridge, T. A. and Fan, C. M. (2011). An absolute requirement for Pax7-
positive satellite cells in acute injury-induced skeletal muscle regeneration.
Development 138, 3639-3646.
Lian, I., Kim, J., Okazawa, H., Zhao, J., Zhao, B., Yu, J., Chinnaiyan, A., Israel,
M. A., Goldstein, L. S., Abujarour, R. et al. (2010). The role of YAP transcription
coactivator in regulating stem cell self-renewal and differentiation. Genes Dev. 24,
1106-1118.
Mahoney, W. M., Jr, Hong, J. H., Yaffe, M. B. and Farrance, I. K. (2005). The
transcriptional co-activator TAZ interacts differentially with transcriptional enhancer
factor-1 (TEF-1) family members. Biochem. J. 388, 217-225.
Mauro, A. (1961). Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9,
493-495.
Maeda, T., Chapman, D. L. and Stewart, A. F. (2002). Mammalian vestigial-like 2, a
cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle
differentiation. J. Biol. Chem. 277, 48889-48898.
McCarthy, J. J., Mula, J., Miyazaki, M., Erfani, R., Garrison, K., Farooqui, A. B.,
Srikuea, R., Lawson, B. A., Grimes, B., Keller, C. et al. (2011). Effective fiber
hypertrophy in satellite cell-depleted skeletal muscle. Development 138, 3657-3666.
McCroskery, S., Thomas, M., Maxwell, L., Sharma, M. and Kambadur, R. (2003).
Myostatin negatively regulates satellite cell activation and self-renewal. J. Cell Biol.
162, 1135-1147.
Mielcarek, M., Gu¨nther, S., Kru¨ger, M. and Braun, T. (2002). VITO-1, a novel
vestigial related protein is predominantly expressed in the skeletal muscle lineage.
Mech. Dev. 119 Suppl. 1:, S269-S274.
Mizuno, T., Murakami, H., Fujii, M., Ishiguro, F., Tanaka, I., Kondo, Y., Akatsuka,
S., Toyokuni, S., Yokoi, K., Osada, H. et al. (2012). YAP induces malignant
mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting
genes. Oncogene 31, 5117-5122.
Mourikis, P., Sambasivan, R., Castel, D., Rocheteau, P., Bizzarro, V. and
Tajbakhsh, S. (2012). A critical requirement for notch signaling in maintenance of
the quiescent skeletal muscle stem cell state. Stem Cells 30, 243-252.
Oka, T., Schmitt, A. P. and Sudol, M. (2012). Opposing roles of angiomotin-like-1 and
zona occludens-2 on pro-apoptotic function of YAP. Oncogene 31, 128-134.
Ono, Y., Calhabeu, F., Morgan, J. E., Katagiri, T., Amthor, H. and Zammit, P. S.
(2011). BMP signalling permits population expansion by preventing premature
myogenic differentiation in muscle satellite cells. Cell Death Differ. 18, 222-234.
Otto, A., Schmidt, C., Luke, G., Allen, S., Valasek, P., Muntoni, F., Lawrence-Watt,
D. and Patel, K. (2008). Canonical Wnt signalling induces satellite-cell proliferation
during adult skeletal muscle regeneration. J. Cell Sci. 121, 2939-2950.
Pallafacchina, G., Franc¸ois, S., Regnault, B., Czarny, B., Dive, V., Cumano, A.,
Montarras, D. and Buckingham, M. (2010). An adult tissue-specific stem cell in its
niche: a gene profiling analysis of in vivo quiescent and activated muscle satellite
cells. Stem Cell Res. 4, 77-91.
Pan, D. (2010). The hippo signaling pathway in development and cancer. Dev. Cell 19,
491-505.
Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time
RT-PCR. Nucleic Acids Res. 29, e45.
Pobbati, A. V., Chan, S. W., Lee, I., Song, H. and Hong, W. (2012). Structural and
functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes.
Structure 20, 1135-1140.
Qiu, H., Wang, F., Liu, C., Xu, X. and Liu, B. (2011). TEAD1-dependent expression
of the FoxO3a gene in mouse skeletal muscle. BMC Mol. Biol. 12, 1.
Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C. and Melton, D. A.
(2002). ‘‘Stemness’’: transcriptional profiling of embryonic and adult stem cells.
Science 298, 597-600.
Relaix, F. and Zammit, P. S. (2012). Satellite cells are essential for skeletal muscle
regeneration: the cell on the edge returns centre stage. Development 139, 2845-2856.
Journal of Cell Science 125 (24)6018
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
Ribas, R., Moncaut, N., Siligan, C., Taylor, K., Cross, J. W., Rigby, P. W. and
Carvajal, J. J. (2011). Members of the TEAD family of transcription factors regulate
the expression of Myf5 in ventral somitic compartments. Dev. Biol. 355, 372-380.
Sacco, A., Doyonnas, R., Kraft, P., Vitorovic, S. and Blau, H. M. (2008). Self-renewal
and expansion of single transplanted muscle stem cells. Nature 456, 502-506.
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K.,
Schiaffino, S., Lecker, S. H. and Goldberg, A. L. (2004). Foxo transcription factors
induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle
atrophy. Cell 117, 399-412.
Saucedo, L. J. and Edgar, B. A. (2007). Filling out the Hippo pathway. Nat. Rev. Mol.
Cell Biol. 8, 613-621.
Scharner, J. and Zammit, P. S. (2011). The muscle satellite cell at 50: the formative
years. Skelet. Muscle 1, 28.
Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D.,
Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R. et al. (2011).
Yap1 acts downstream of a-catenin to control epidermal proliferation. Cell 144, 782-
795.
Sudol, M. and Harvey, K. F. (2010). Modularity in the Hippo signaling pathway.
Trends Biochem. Sci. 35, 627-633.
Sun, G., Haginoya, K., Wu, Y., Chiba, Y., Nakanishi, T., Onuma, A., Sato, Y.,
Takigawa, M., Iinuma, K. and Tsuchiya, S. (2008). Connective tissue growth factor
is overexpressed in muscles of human muscular dystrophy. J. Neurol. Sci. 267, 48-56.
Tatsumi, R., Anderson, J. E., Nevoret, C. J., Halevy, O. and Allen, R. E. (1998).
HGF/SF is present in normal adult skeletal muscle and is capable of activating
satellite cells. Dev. Biol. 194, 114-128.
Tintignac, L. A., Lagirand, J., Batonnet, S., Sirri, V., Leibovitch, M. P. and
Leibovitch, S. A. (2005). Degradation of MyoD mediated by the SCF (MAFbx)
ubiquitin ligase. J. Biol. Chem. 280, 2847-2856.
Tomczak, K. K., Marinescu, V. D., Ramoni, M. F., Sanoudou, D., Montanaro, F.,
Han, M., Kunkel, L. M., Kohane, I. S. and Beggs, A. H. (2004). Expression
profiling and identification of novel genes involved in myogenic differentiation.
FASEB J. 18, 403-405.
Vassilev, A., Kaneko, K. J., Shu, H., Zhao, Y. and DePamphilis, M. L. (2001).
TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-
associated protein localized in the cytoplasm. Genes Dev. 15, 1229-1241.
Watt, K. I., Judson, R., Medlow, P., Reid, K., Kurth, T. B., Burniston, J. G.,
Ratkevicius, A., De Bari, C. and Wackerhage, H. (2010). Yap is a novel regulator
of C2C12 myogenesis. Biochem. Biophys. Res. Commun. 393, 619-624.
Yamada, M., Tatsumi, R., Yamanouchi, K., Hosoyama, T., Shiratsuchi, S., Sato, A.,
Mizunoya, W., Ikeuchi, Y., Furuse, M. and Allen, R. E. (2010). High
concentrations of HGF inhibit skeletal muscle satellite cell proliferation in vitro by
inducing expression of myostatin: a possible mechanism for reestablishing satellite
cell quiescence in vivo. Am. J. Physiol. Cell Physiol. 298, C465-C476.
Yoshida, T. (2008). MCAT elements and the TEF-1 family of transcription factors in
muscle development and disease. Arterioscler. Thromb. Vasc. Biol. 28, 8-17.
Yoshihama, Y., Chida, K. and Ohno, S. (2012). The KIBRA-aPKC connection: A
potential regulator of membrane trafficking and cell polarity. Commun. Integr. Biol.
5, 146-151.
Yu, F. X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J.,
Yuan, H., Tumaneng, K., Li, H. et al. (2012). Regulation of the Hippo-YAP
pathway by G-protein-coupled receptor signaling. Cell 150, 780-791.
Zammit, P. S., Golding, J. P., Nagata, Y., Hudon, V., Partridge, T. A. and
Beauchamp, J. R. (2004). Muscle satellite cells adopt divergent fates: a mechanism
for self-renewal? J. Cell Biol. 166, 347-357.
Zammit, P. S., Relaix, F., Nagata, Y., Ruiz, A. P., Collins, C. A., Partridge, T. A. and
Beauchamp, J. R. (2006). Pax7 and myogenic progression in skeletal muscle satellite
cells. J. Cell Sci. 119, 1824-1832.
Zhang, H., Deo, M., Thompson, R. C., Uhler, M. D. and Turner, D. L. (2012).
Negative regulation of Yap during neuronal differentiation. Dev. Biol. 361, 103-115.
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C. Y.,
Chinnaiyan, A. M. et al. (2008). TEAD mediates YAP-dependent gene induction
and growth control. Genes Dev. 22, 1962-1971.
Zhao, B., Li, L., Tumaneng, K., Wang, C. Y. and Guan, K. L. (2010). A coordinated
phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP).
Genes Dev. 24, 72-85.
Zhao, B., Li, L., Lu, Q., Wang, L. H., Liu, C. Y., Lei, Q. and Guan, K. L. (2011).
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.
Genes Dev. 25, 51-63.
Yap in satellite cells 6019
